about
Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complicationsLow-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorderEnoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromesFamilial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolismLow-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM).Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Monitoring the effects and managing the side effects of anticoagulation during pregnancy.Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial.Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial.[Ischemic colitis as a manifestation of Moschkowitz's syndrome]Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes.A common polymorphism in NR1H2 (LXRbeta) is associated with preeclampsia.APC resistance and third-generation oral contraceptives: Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease.Coagulation and placenta-mediated complications.Coagulation and mental disordersPolymorphisms of human placental alkaline phosphatase are associated with in vitro fertilization success and recurrent pregnancy loss.Impaired fibrinolytic capacity and early recurrent spontaneous abortionApheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.Relationship between Plasma D-Dimer Concentration and Three-Dimensional Ultrasound Placental Volume in Women at Risk for Placental Vascular Diseases: A Monocentric Prospective Study.Association of FOXD1 variants with adverse pregnancy outcomes in mice and humans.Homocysteine and venous thrombosis.The association between hereditary thrombophilias and pregnancy loss.Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred studyProphylaxis and treatment of thrombophilia in pregnancy.Impact of assisted reproduction treatments on Spanish newborns: report of 14,119 pregnancies.Analysis of genes coding for CD46, CD55, and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy lossInterleukin 10 gene promoter polymorphisms in women with pregnancy loss: preferential association with embryonic wastage.Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis.Antiphospholipid syndrome: looking for a refocusing.Mental disorders and thrombotic risk.Antiphospholipid antibodies: neuropsychiatric presentations.Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells.Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies.Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?Regulatory T cells, maternal-foetal immune tolerance and recurrent miscarriage: new therapeutic challenging opportunities.Neuropsychiatric presentations of antiphospholipid antibodies.Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.Association of common eNOS/NOS3 polymorphisms with preeclampsia in Tunisian Arabs.
P50
Q27027687-EE907D7D-D7F4-4812-AB5E-FBBAB2F6914FQ28166888-36C814C8-2B60-4F03-A2B6-76049E1FBEE1Q28192633-CDC88245-4AAB-434E-8F65-AB3A901525FDQ28268430-9545017B-19FC-498B-BB27-3761D89408BBQ30833556-0FB79695-214D-4AE4-870E-CA28D3F0A3A7Q31135729-0A9C2534-648B-4FD7-A77A-80A52DFF9DD1Q33341941-76BE4678-0312-438A-AD1A-3F0478C752A5Q33372588-3A646391-6702-466F-815B-F55383D9FA74Q33391284-AACFF80B-B1C0-4A38-A7A0-A0EF9DB1588BQ33397334-92D6A9F7-0DE7-458F-A25F-3165772D821EQ33431812-04AA4D58-093D-48A2-A9B9-16D95FC50234Q33815975-DA66A703-BFFF-4588-9826-A0C1B949A8ACQ34059001-2F37F606-E836-431C-98FE-928BBED0B769Q34119368-39D35213-2531-426D-9096-C782DC1B0082Q34463447-93F2A0A0-1E6B-4F42-8013-3694F932CC70Q34463453-60566243-64C3-4C71-A7FD-3EBB8638F206Q35057605-70937F17-C1AA-4A09-BD28-EF330EFAE96BQ35169528-BB81CEA9-D10B-407B-B68D-6527A1C7554CQ35905474-58B9F847-20F9-43B7-8BBE-01A27BECECBFQ36050130-292188F2-B497-47C2-A227-6B918225795EQ36180170-43419B81-8C4F-4440-86B7-D0DFBD20221EQ36208967-A749FBD0-58A9-4B00-9173-D4913079A276Q36254535-A26B1605-1454-41B4-970C-3FFF1A6E7AEDQ36318204-D68BDBF2-EB5E-4E83-9503-F6FFEF0E2530Q36556455-1AC2C9BD-4184-43BE-9E1A-3CDEA9879EA6Q37049978-2A0EEBD8-F897-4C38-82BB-830AC2341476Q37139451-96A3A133-F3CF-453B-B871-444C77FF5763Q37390137-4E486250-46BA-4356-A0E8-C9DAD777FDE3Q37692536-9493A733-57BE-44D8-AB78-E4C8CE996825Q38085780-FD4A1F14-472E-4B47-90E8-D107D1370F83Q38151482-A4BF888B-1691-4A8D-A225-09867994083DQ38152972-E2AF1AD0-2A16-4CA8-8288-E607ECB48A5AQ38192184-3289A107-29F8-465A-B153-A920E7682570Q38193203-C9FB17D5-E96F-49F8-B9B8-10A92AF68944Q38196904-F6BFC4E8-0C88-49F0-B5EF-94A410725D18Q38198828-0C351A26-376B-4F5A-88FD-17D3E33FCB70Q38199273-5C4AEB17-380F-47BB-9421-4A6467D5BCF8Q38436403-AD151658-28DD-4A56-9360-BDB65412B4B6Q38901711-D68866B4-707C-433D-9E15-F0D9EDF01D4BQ38901715-7644A673-C363-4CE6-854D-57A417EA4260
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jean-Christophe Gris
@ast
Jean-Christophe Gris
@en
Jean-Christophe Gris
@es
Jean-Christophe Gris
@nl
type
label
Jean-Christophe Gris
@ast
Jean-Christophe Gris
@en
Jean-Christophe Gris
@es
Jean-Christophe Gris
@nl
prefLabel
Jean-Christophe Gris
@ast
Jean-Christophe Gris
@en
Jean-Christophe Gris
@es
Jean-Christophe Gris
@nl
P106
P31
P496
0000-0002-9899-9910